ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is a common subtype of non‐small cell lung cancer with high morbidity and mortality rates and is usually detected at advanced stages because of the early onset of metastasis. Adenosine deaminase RNA‐specific 1 (ADAR1) is an RNA editing enzyme that catalyzes the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wendi, Chen, Kehong, Yu, Qian, Liao, Rongxin, He, Hengqiu, Peng, Yuan, Yang, Zhenzhou, Zhang, Xiaoyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358204/
https://www.ncbi.nlm.nih.gov/pubmed/37162299
http://dx.doi.org/10.1002/cam4.6044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358204/
https://www.ncbi.nlm.nih.gov/pubmed/37162299
http://dx.doi.org/10.1002/cam4.6044

Ejemplares similares